Success Stories: EB1A Approval Secured for a Biomedical Scientist from India, Advancing Global Cancer Research

Client’s Testimonial:

“I am very thankful to the team’s support and continuous guidance throughout my EB1 process, as well as my previous NIW process. They are very professional, meticulous, responsive, and very detailed. They know all the immigration processes in depth and guide you with all the details. I appreciate all their help and recommend them to anyone going through the same journey.”

On May 15^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Staff Scientist in the Field of Translational Science (Approval Notice).

General Field: Translational Science

Position at the Time of Case Filing: Staff Scientist

Country of Origin: India

State of Residence at the Time of Filing: Washington

Approval Notice Date: May 15^th, 2025

Processing Time: 1 year, 3 months, 8 days (Premium Processing Requested)

Case Summary:

A pioneering researcher in the field of translational science and therapeutics from India recently received I-140 approval under the EB1A (Alien of Extraordinary Ability) category, affirming her exceptional contributions to cancer biomarker discovery and therapeutic target development. The petition, initially filed on February 7, 2024, was officially approved on May 15, 2025. This case reflects not only scientific excellence but also the strategic advocacy required for high-standard immigration success.

Uncovering Molecular Mechanisms Behind Cancer and Disease

Our client’s research has consistently broken ground in cancer proteomics, myeloid malignancies, and biomolecular diagnostics. Her work spans the identification of biomarkers in acute myeloid leukemia, investigation of protein mis-splicing mechanisms, and the analysis of therapeutic targets in retinoblastoma and other cancers. Additionally, she has led impactful studies in veterinary proteomics, including the detection of novel diagnostic proteins in bovine urine.

She is currently employed in a U.S.-based medical research institute, where she continues to expand her work in biomarker-based cancer stratification and targeted therapies.

Objective Evidence of Extraordinary Ability

In building her EB1A petition, we demonstrated through rigorous documentation that she is one of the few researchers in her field to have achieved such a comprehensive and sustained impact:

● 18 peer-reviewed articles and 1 conference abstract published in top-ranked journals, including Blood, Haematologica, and Journal of Proteomics;

● 350 citations across scholarly literature, with her most-cited paper ranking among the top 1% most cited in Biology & Biochemistry for its year of publication;

● 10 completed peer reviews for high-impact journals such as Biomarker Research and Journal of Hematology and Oncology, reflecting her role as a trusted authority;

● Funding support from prestigious institutions, including the National Cancer Institute and National Agricultural Science Fund, confirms the societal and scientific merit of her work.

● Her published work has been relied upon by researchers in over 40 countries, spanning Europe, Asia, the Americas, and beyond.

Endorsements from International Experts

The petition included four letters of recommendation from globally respected scientists who offered compelling testimonials to her international recognition and significance in the field. These recommenders, based in the U.S., Spain, and Mexico, emphasized the originality and reach of her research.

One recommender wrote:

“Her contributions to the field—particularly in the discovery of splicing-associated cancer phenotypes and molecular diagnostics—have not only influenced clinical research strategies but also informed therapeutic innovations currently being explored in hematological malignancies.”

One Approval, Many Frontiers

This approval under the EB1A category marks a significant milestone in the client’s journey. She even received her NIW approval with us in the past. Her research continues to illuminate new pathways for early cancer detection, precision medicine, and innovative immunotherapies.

We are proud to have played a role in presenting a case that did justice to her work. As she continues to contribute to biomedical science from within the United States, we have no doubt that her efforts will deliver tangible benefits to patients, clinicians, and the global scientific community.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.